From star signs to trial guidelines

被引:23
作者
Horton, R [1 ]
机构
[1] The Lancet, London WC1X 8RR, England
关键词
D O I
10.1016/S0140-6736(00)02031-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1033 / 1034
页数:2
相关论文
共 6 条
[1]  
[Anonymous], 1988, LANCET, V2, P349
[2]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[3]   Inadequate reporting of controlled trials as short reports [J].
Deeks, JJ ;
Altman, DG .
LANCET, 1998, 352 (9144) :1908-1908
[4]   CONSORT: An evolving tool to help improve the quality of reports of randomized controlled trials [J].
Moher, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1489-1491
[5]   Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement [J].
Moher, D ;
Cook, DJ ;
Eastwood, S ;
Olkin, I ;
Rennie, D ;
Stroup, DF .
LANCET, 1999, 354 (9193) :1896-1900
[6]   ANALYSIS AND INTERPRETATION OF TREATMENT EFFECTS IN SUBGROUPS OF PATIENTS IN RANDOMIZED CLINICAL-TRIALS [J].
YUSUF, S ;
WITTES, J ;
PROBSTFIELD, J ;
TYROLER, HA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (01) :93-98